Image from Amazon.com
Biological Drugs: Challenges to Access
Material type:
TextPublication details: Malaysia: Third World Network, 2018.Description: 38pISBN: - 978-967-0747-26-2
- The Growing Therapeutic and Commercial Importance
- How Biological Drugs Differ from Small Molecule Drugs
- Recombinant Technologies in the Manufacture of Biological Drugs
- Renewed Interest in Biological Medicines
- Why are Biologics and Biosimilars So Expensive
- Biosimilas vs Generics of SMDs
- Technological Barriers to Manufacture of Biosimilars
- Barriers Related to Intellectual Property Rights and Data Exclusivity
- The Evolving Regulatory Landscape for Approval of Biosimilars
- How necessary are Present Requirements to Establish Similarity
- 615.32 AMI
| Item type | Current library | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
Closed Reference
|
IUCIPRS Reference | 615.32 AMI (Browse shelf(Opens below)) | Not for loan | IPR4407 |
Browsing IUCIPRS shelves, Shelving location: Reference Close shelf browser (Hides shelf browser)
| No cover image available | No cover image available | No cover image available |
|
|
|
|
||
| 614 FIN;1 Public health in the 21st century. | 614 FIN;2 Public health in the 21st century. | 614 FIN;3 Public health in the 21st century. | 615.32 AMI Biological Drugs: Challenges to Access | 615.45:34 ROS The law of chemical and pharmaceutical invention : patent and nonpatent protection | 615.45:347.771 GRO;1 Biotechnology and pharmaceutical patents : law and practice. | 615.45:347.771 GRO;2 Biotechnology and pharmaceutical patents : law and practice. |
There are no comments on this title.